Background: Increased body weight may influence airway inflammatory mechanisms. Objective: To assess whether overweight-obesity (OW-O), evaluated as increased body mass index, is associated either with exhaled nitric oxide (eNO), a marker of airway inflammation, or with allergic sensitization in a large sample of children and adolescents.
INTRODUCTION
Epidemiological surveys have shown a trend to increasing prevalence of asthma 1 and obesity 2 over the last decades. Because both asthma and obesity are characterized by inflammatory processes, mechanisms based on common pathways, such as endocrine factors including adipokines and reproductive hormones, 3 have been proposed as a plausible explanation for the association between the 2 conditions. 4, 5 In fact, a higher adiposity in infancy has been recently demonstrated to be associated with increased risk of recurrent wheezing during childhood, 6 and increased body weight may influence airway inflammatory mechanisms, 7 even though underlying mechanisms have not been completely elucidated. 8 Exhaled nitric oxide (eNO) is a useful noninvasive marker of airway inflammation, 9 particularly in children with asthma. 10 A highly significant correlation with blood eosinophilia was found in children with mild to moderate persistent asthma followed by the Childhood Asthma Research and Education Network supported by the National Heart, Lung, and Blood Institute. 11 Indeed, the interest in eNO is based on the assumptions that eNO is a marker of asthma and asthma control, and that it reflects eosinophilic airway inflammation. However, the literature remains inconclusive. 12 Few studies have investigated the relationships between body mass index (BMI) and eNO in pediatric populations. In 40 nonatopic children (range, 6 -18 years) with no history of respiratory diseases, no relationship was detected between eNO and age-and sex-corrected body mass index. 13 In addition, when asthma was taken into account, eNO levels did not differ between obese and nonobese asthmatic children. 14 Similarly, eNO was not correlated to adiposity among adolescents with moderate to severe asthma. 15 Although allergic sensitization is an important phenotype in children with asthma and a factor able to influence eNO levels per se, 16 few and controversial data exist on the relationship between obesity and atopy. In fact, an increased BMI was a significant predictor of atopy in children, 17 but only in girls. Conversely, no association was found between BMI and self-reported allergy in a large Italian population sample. 18 Similarly, no independent relationship between BMI and atopy-as assessed by skin prick tests-was found in US children. 19 Thus, the association of increased body weight with allergic sensitization, elevated eNO, and asthma symptoms is controversial. These factors-body weight, eNO, allergic sensitization, and asthma symptoms-have not been evaluated simultaneously from a general population sample of older children.
The aim of our cross-sectional study was to assess whether overweight-obesity (OW-O) per se is associated with higher exhaled nitric oxide or increased prevalence of allergic sensitization and asthma in a large sample of schoolchildren aged 10 to 16 years, investigated by means of questionnaires, spirometry, and skin prick tests.
METHODS

Patient Population
This cross-sectional study was carried out in a general population sample of 10-to 16-year-old schoolchildren from 16 schools selected on the basis of their geographical distribution among the 59 junior high schools of Palermo (680,000 inhabitants), Southern Italy, during November 2005 to May 2006. The entire student population of the 16 schools was 9,922 children. From this group, we randomly selected 2,481 children (1 of every 4). Three hundred three children did not obtain parental consent or were not present at school in the day of the study. Thus 2,178 children completed a respiratory health questionnaire and underwent lung function testing and skin prick test (SPT) at school. Among them, 28 children refused SPT or were not able to perform a valid spirometry. Finally, 2,150 children were completely evaluated by questionnaire, lung function testing, and SPT at school.
Except for asthma, no other chronic pulmonary disease was reported.
Study Parameters
Following the Italian SIDRIA Study (Studio Italiano Disturbi Respiratori Infanzia e Ambiente), 20 which, in turn, adopted the standardized method of the International Study of Athma and Allergies in Childhood, 21 a child's history of "asthma ever" was defined as a positive answer to the question "Have you ever had asthma?" Rhinoconjunctivitis was defined as a positive answer to both the questions "Have you ever had a problem with sneezing, or runny, or blocked nose apart from common cold or flu in the last 12 months?" and "In the past 12 months, has this nose problem been accompanied by itching and/or watering eyes?" For the analyses, 3 subgroups were considered: patients with asthma, regardless of the presence of rhinoconjunctivitis (A); subjects with rhinoconjunctivitis (RC); and subjects without asthma or RC (nAnRC). Consequently, individuals with both asthma and rhinoconjunctivitis were classified as A, whereas RC included only subjects with rhinoconjunctivitis alone.
Skin prick tests were performed according to European Academy of Allergy and Clinical Immunology recommenda-tions 22 with a standard panel including Dermatophagoides mix, grass mix, Parietaria judaica, olive, dog and cat dander, Alternaria alternata, and Blattella germanica, plus a positive (histamine 1%) and a negative (saline) control (Stallergènes Italia S.r.l., Milan, Italy). The reading was performed after 15 minutes: reactions were considered positive if the mean wheal diameter (computed as the maximum diameter plus its orthogonal divided by 2) was 3 mm or larger, after having subtracted the wheal diameter of the reaction to the negative control. Allergic sensitization was defined as the presence of at least 1 positive skin prick test.
Height and weight were measured in all of the children in standing position without shoes, using a stadiometer and an electronic digital scale: BMI was computed as weight/height 2 (kg/m 2 ). Overweight-obese children were defined as BMI larger than the age-and sex-specific 85 th percentiles of the studied population sample. 23 Pulmonary function tests were performed by a portable spirometer (MicroLoop, Micro Medical, Chatham Maritime, Kent, United Kingdom). Forced expiratory volume in 1 second (FEV 1 ), forced vital capacity (FVC) and maximum midexpiratory flow (FEF 25-75% ) were measured according to American Thoracic Society and European Respiratory Society guidelines: The best FVC and FEV 1 were retained, and FEF 25-75% was selected from the maneuver with the largest sum of FEV 1 and FVC. 24 The FEV 1 /FVC% ratio was computed as best FEV 1 /best FVC. Spirometric predicted values were those from Pistelli et al., 25 derived from an Italian population sample. An impaired pulmonary function was defined when FEV 1 /FVC% was below the 5 th percentile of its normal distribution (87% of predicted for boys and 90% for girls). 25 
Nitric Oxide Measurements
Because we could not study the entire sample by eNO analysis, because of resources limitations, among 2,150 subjects who completed the baseline evaluation, 717 children were randomly selected (one every three subjects) and evaluated by off-line eNO measurements using single exhalations with constant flow by a dynamic-flow restrictor following American Thoracic Society and the European Respiratory Society recommendations. 26 The exhaled gas was collected into NOinert 4-L mylar bags 27 and analyzed within 4 hours by a chemiluminescence analyzer connected to a computerized system (NIOX, Aerocrine AB, Stockholm, Sweden). The instrument had a sensitivity of 1.5 part per billion (ppb), a detection range of 0 to 200 ppb, and a response time of less than 0.8 s, and was calibrated with a certified NO gas mixture. Finally, 9 individuals were not able to perform a valid maneuver; thus, 708 children had eNO data were available for the analysis.
The study was approved by the Institutional Review Board of the University Hospitals of Palermo, and all children had a written informed consent signed by a parent. The respect of individual privacy concerning clinical data was granted according to the Italian law.
Statistical Analyses
One-way and two-way analysis of variance (ANOVA) and frequency distribution tables ( 2 ) for parametric variables were performed: because the distribution of eNO values was highly skewed, analysis was performed after natural log transformation (ln eNO). Nonparametric Mann-Whitney Utest was used when appropriate. To study the independent variables able to influence the risk for elevated eNO levels, eNO was dichotomized at the level of its 75 th percentile, and a logistic regression model was used to explore the relationships between the dependent variable (eNO) and independent variables (BMI, impaired lung function, atopy, presence of asthma, or rhinitis), adjusting for sex. Odds ratios with corresponding 95% confidence intervals (CI) were calculated for all predictors. All computations were performed by StatView statistical software package (SAS Institute, Cary, North Carolina). A probability level of P Ͻ .05 was selected as being statistically significant.
RESULTS
The 708 subjects who performed eNO measurements (352 males, 49.7%) were not significantly different compared with the whole population sample (N ϭ 2,150) as concerns age, sex, allergic sensitization, BMI, symptoms, and lung function ( Table 2 ). Similarly, obesity was not associated with increased eNO in A, RC, and nAnRC subgroups compared with nonobese (Mann-Whitney U-test, Table 3A ). Moreover, no difference was found in distribution of subjects with allergic sensitization between OW-O and non-OW-O in both A and RC subgroups (Table 3B ).
In a two-way ANOVA model, allergic sensitization but not OW-O was associated with a significant increase of eNO ( Fig  1) . In fact, exhaled nitric oxide (median and interquartile range) was 20.3 (12.9 -35.8) ppb among subjects with positive SPT and 13.9 (10.6 -18.3) ppb among subjects without positive SPT (P Ͻ .0001, ANOVA, after natural log transformation). When the combination of asthma ever and allergic sensitization was taken into account, eNO was not significantly more elevated in OW-O children (Fig 2) .
When evaluated in different logistic models, OW-O was a significant risk factor for both A (Table 4 ) and allergic sensitization ( Table 5 ). By a logistic regression model, presence of allergic sensitization, asthma ever, and rhinoconjunctivitis were significant predictors of increased eNO. In the same model, neither OW-O nor impaired lung function were significant risk factors for increased eNO (Table 6 ).
DISCUSSION
In this cross-sectional study of schoolchildren, aged 10 to 16 years, no evidence of eosinophilic airway inflammation, as evaluated through exhaled nitric oxide measurements, was found in overweight-obese children. Nevertheless, we confirmed that OW-O was associated with asthma ever and allergic sensitization (Fig 3) . Moreover, asthma, rhinocon- All the differences were not statistically significant ( 2 test for categorical variables and ANOVA for continuous variables). a Overweight-obese children were defined as BMI greater than the age-and sex-specific 85 th percentiles of the studied population sample. 27 junctivitis, and, mainly, allergic sensitization were independent risk factors for increased eNO levels. No significant effect of pulmonary function on exhaled NO levels was found.
Although BMI is only a proxy for adiposity, 28 it is easy to measure in epidemiological studies. Because BMI changes significantly with age and sex in childhood, 29 overweightobesity cutoff levels were selected according to the age-and sex-related 85 th percentiles of the BMI distribution computed on the whole sample. Indeed, a BMI greater than 85 th per- centile yields an elevated specificity for identifying subjects with increased body fat, 30 also ensuring a sufficient number of OW-O for statistical comparisons.
The prevalence of OW-O was 16.4% among our study population. This subgroup showed higher prevalence rates of asthma ever and allergic sensitization. Asthma ever was approximately twofold more frequent among OW-O compared with non-OW-O subjects, in agreement with the results of a recent meta-analysis providing the evidence for the association of asthma and obesity. 31 However, controversial results exist in children, 32, 33 possibly depending on different approaches to asthma and obesity definitions, muscle mass, or hormone-related differences. 34 We found an association between OW-O and asthma in our schoolchildren regardless of sex (Table 4 ). Conversely, Gilliland et al 23 reported an increased risk of new-onset asthma in overweight and obese boys, and Schachter et al 17 did not find any association between high BMI and diagnosed or current asthma in 7-to 12-year-old children, in either boys or girls. Different asthma definitions, resulting in different asthma prevalence, and different population samples can account for these controversial results.
Considering airway caliber indicators, OW-O subjects did not show significantly reduced FEV 1 /FVC and FEF 25/75% either in the overall sample or in the asthmatic subgroup, suggesting that OW-O does not produce per se any significant effect on airway obstruction. Considering lung volume indicators, the significant FEV 1 and FVC decreases (as percentage of predicted), at a similar extent, in OW-O could be attributable to a limited expansion of the lungs as an effect of chest compression. 35 Our findings are in agreement with the results reported by Li et al, 36 who did not find any correlation between obesity and both FEV 1 and FVC in a sample of obese children. Conversely, our findings differ from those of Chen et al, 37 who found a negative correlation between obesity, as measured by waist circumference, and FEV 1 /FVC, and from those of Kattan et al, 15 reporting worse asthma control and poorer pulmonary function in female obese adolescents. In the latter paper, possible sex-related mechanisms (other than atopy and inflammation) were advocated for explaining these differences.
We found a significantly higher prevalence of subjects with allergic sensitization in OW-O (51.6%) compared with nonobese (37.0%). Controversial results have been reported in previous pediatric studies: allergic sensitization was not increased in OW-O, 34 and atopic girls (not boys) were more frequent among subjects with high BMI. 17 Exhaled NO values do not significantly differ between OW-O and subjects with a normal weight both in the whole sample and in the subgroups with asthma ever or rhinoconjunctivitis. These results are consistent with a recent study reporting no significant differences in eNO values in obese healthy children compared with nonobese controls. 38 Similarly, Buchvald et al 39 showed that eNO levels were not related to BMI in 4-to 17-year-old healthy children. Moreover, no significant relationship between eNO and BMI was Data are expressed as odds ratio (OR) and 95% confidence interval (95% CI). Data are expressed as odds ratio (OR) and 95% confidence interval (95% CI) and corrected for impaired lung function and presence of rhinoconjunctivitis. a Cutoff level at 75 th percentile of eNO distribution. Data are expressed as odds ratio (OR) and 95% confidence interval (95% CI) and corrected for sex and impaired lung function. a Cutoff level at 75 th percentile of eNO distribution. Figure 3 . Effect of overweight-obesity (OW-O) on the investigated variables. OW-O was not associated with increased exhaled nitric oxide (eNO) levels, but it was an independent risk factor for asthma ever and allergic sensitization, which, in turn, were independently associated with increased eNO levels.
found in asthmatic subjects, 40 and childhood obesity was not associated with increased airway inflammation. 41 Conversely, De Winter-de Groot et al 42 showed that exhaled nitric oxide was positively associated with BMI in healthy adults and suggested a direct or indirect upregulation of inflammatory processes in the airways influenced by obesity. However, individual atopic status was not evaluated, and BMI was limited to the range 18 to 29 kg/m 2 .
We found that OW-O was not associated with a significant increase in eNO in the total sample, nor in each A, RC, or nAnRC subgroup. Similarly, eNO was not significantly different among OW-O subjects in any combination of presence of asthma ever and allergic sensitization (Fig 2) . A possible explanation for this result might be an information bias (eg, overdiagnosis of asthma attributable to nonspecific obesityrelated respiratory symptoms among obese children). In fact, recent meta-analyses have pointed out that some obese patients with "asthma" may have respiratory symptoms caused by obesity without objective physiological criteria for asthma 3 or an exaggerated symptom perception. 4 Asthma ever, rhinoconjunctivitis, and, mainly, allergic sensitization were the only variables able to significantly increase the risk for a high eNO level, as already demonstrated in a study on a general population sample previously conducted by our group. 16 Despite the fact that in the current sample no different marker of airway inflammation was available, we believe, as repeatedly reported in the literature, that allergic sensitization is one of the single most important factors affecting the association between eNO and different markers of eosinophilia. 11, 12 In other words, a correct interpretation of eNO values should always be based on the knowledge of the atopic status of investigated subjects.
Thus, in view of the results of the applied methods, we cannot share the hypothesis that, in overweight-obese children, systemic inflammatory mechanisms of obesity may produce an increase in eosinophilic airway inflammation, as recently suggested by Sutherland et al. 7 Moreover, the lack of increased bronchial hyperresponsiveness in obese children 17 further supports the hypothesis that obesity and airway inflammation are not associated conditions. Conversely, a recent report from Wood et al 43 suggests that high-fat meals may augment neutrophilic airway inflammation. This controversial experimental evidence suggests that additional investigation is required for exploring common pathways possibly linking adiposity and airway inflammation.
In conclusion, our findings suggest that overweight-obesity per se does not have a significant effect on airway inflammation as measured by exhaled nitric oxide in a large sample of children and adolescents. However, our study confirms that overweight-obesity is an independent risk factor for asthma and allergic sensitization, which, in turn, are associated with airway inflammation. Thus, among older children, overweight-obesity may represent a significant burden for later health consequences.
